Cite
APA Citation
Sun, R., Champiat, S., Dercle, L., Aspeslagh, S., Castanon, E., Limkin, E. J., Baldini, C., Postel-Vinay, S., Hollebecque, A., Massard, C., Ammari, S., Deutsch, E., Soria, J., Marabelle, A., & Ferté, C. (2017). baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors). European journal of cancer, 84, 202–211. http://access.bl.uk/ark:/81055/vdc_100078553475.0x00002d